IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2017 Holdings

Filed 2017-05-15 | 11 holdings | $85.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$84.8M310,00099.0%
Abbvie Inc.(ABBV)COM00287Y109$651.0K10,0000.8%
Medicines CoCOM584688105$85.7K1,752,0000.1%
Innoviva Inc(INVA)COM45781M101$47.4K3,425,0000.1%
Novelion Therapeutics IncCOM NEW67001K202$11.0K1,025,0000.0%
Bioverativ IncCOM09075E100$8.4K155,0000.0%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$5.9K360,0000.0%
Apricus Biosciences IncCOM NEW03832V307$3.1K1,447,9060.0%
Vivus IncCOM928551100$2.9K2,573,9430.0%
Advaxis IncCOM NEW007624208$2.8K339,1800.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$5981,013,6160.0%